newsfilter
← Latest News
Business Wire·

First Patient in Japan Treated with Impella 5.5 with SmartAssist

5,000 Patients Treated Globally The versatility and innovation of Abiomed's (NASDAQ:ABMD) Impella 5.5 with SmartAssist, a minimally-invasive forward flow heart pump, is leading to continued adoption of the game-changing technology by surgeons around